In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30th September, 2022, has been placed on the Company's website at: https://www.torrentpharma.com/pdf/investors/TorrentPharma_Earnings_Q2_2022_23.pdf